April 19th 2024
Amid escalating multidrug-resistant organism threats, hospitals face business risks and patient trust erosion, necessitating improved cleaning and infection prevention practices.
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Special Report on Candida auris: An Emerging Drug-Resistant Fungal Threat
June 14th 2023The recent increase in drug-resistant strains of Candida auris, causing mortality at rates as high as 60%, raises questions regarding the spread of this pathogen as a health care-associated infection, cleaning/disinfecting protocol, and treatment via antifungal drugs.
Retaining and Developing the IPs of Tomorrow: How to Find Meaning as an Infection Preventionist
May 23rd 2023Infection preventionists come from many different backgrounds. However, many left the field during the COVID-19 pandemic. It will require creative methods to preserve existing IP staff and educate those entering the field.
ICT Exclusive: Deborah Birx, MD, Discusses the End of the COVID-19 Public Health Emergency
May 11th 2023“It doesn't matter if the public health emergency goes away or not. Because we haven't taken advantage of the public health emergency over the last 2 years to understand and address the gaps quite apparent to every American out there.”
CDC Discusses Candida auris: Strategies to Help Control and Prevent Outbreaks
May 5th 2023To control C auris, focus on using antibiotics and improving diagnostics. New treatments in development offer hope for better management. This is the fourth and final installment in CDC's interview with the ICT.